NIH-funded research NIH-funded research

Understanding dementia in adults with Down syndrome

Official title: Neurobiological basis for dementia in adults with Down syndrome

Funded at University of California-Irvine · NIH-11288971 · Data updated 2026-11-12

A study with adults who have Down syndrome will explore why cognitive decline and dementia occur, using advanced brain analyses to identify key pathways and potential treatment targets.

More Dementia research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California-Irvine
NIH-funded
Lab location1 site (Irvine, United States)
Project startAugust 1, 2026
Project endJuly 31, 2029
Funding year2026
Award (this year)$6,132,482
NIH project number1RF1AG098213-01
Project IDNIH-11288971 on NIH RePORTER

Who could benefit from this research

Could help

Adults with Down syndrome who have undergone clinical characterization and have brain tissue samples available for research.

Less likely to help

Most participants will contribute tissue data; direct benefits to individuals are not guaranteed.

What this research studies

This project focuses on aging adults with Down syndrome who are at risk for Alzheimer’s-type brain changes. Researchers will use spatial multi-omics to map transcripts, epigenetic marks, and proteins in hundreds of brain samples, aiming to understand why some individuals decline earlier while others show resilience. By examining neuroinflammation, white matter changes, and synaptic function, the study seeks to reveal molecular pathways involved in disease progression. The results will create a rich dataset to speed translational research and identify new targets for therapies. Participation will come from postmortem or brain tissue analyses complemented by clinically characterized samples.

Why it matters

Potential benefit: The findings could lead to new biomarkers and targets for therapies to delay or prevent dementia in people with Down syndrome.

How similar studies have gone: Previous studies show that brain-wide molecular mapping can identify disease pathways and potential targets in neurodegenerative conditions.

Where this research is happening

  • University of California-Irvine
    Irvine, United States
    Active

Researchers

  • Principal investigator: Head, Elizabeth — University of California-Irvine
  • Study coordinator: Head, Elizabeth

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.